"Designing Growth Strategies is in our DNA"

Insulin API Market Size, Share & Industry Analysis By Type (Regular Human Insulin, Insulin Analogue, Others), By End-user (Fast-acting, Long-acting, Premix) And Regional Forecast 2023-2030

Region : Global | Report ID: FBI105610 | Status : Ongoing



Insulin is an important drug used to treat used to treat patient who have diabetes. It is used to treat patients with type 1 and type 2 diabetes where type 1 diabetes is a condition in which body does not product insulin and type 2 diabetes results from the body’s ineffective use of insulin and therefore unable to control the amount of sugar in blood. In 2018,as per BMJ Global Health, around 100 million people need insulin worldwide. The growing production of insulin to meet the demand of diabetic people and increase in the product development are the major factors estimated to contribute in the inslulin API market etc.

The rising prevalence of diabetes among the population worldwide is estimated to drive the market in the coming years. For instance, according to WHO, diabetes prevalence has been rising more speedily in low and middles income class countries and it is the seventh leading cause of death. In 2019, around 1.5 million deaths were caused by diabetes. Additionally, Biocon company has successfully taken a range of novel biologics and affordable recombinant human insulin and insulin analogs from ‘Lab to Market’

However, the high cost for insulin create a barrier for the insulin API market as major population are from low and middle income countries. Type 1 diabetic people need insulin for survival but as per WHO, low and middle income countries are not receiving it due to high prices and supply challenges. Major problem with insulin cost is that few companies are controlling control 96% of the global market, setting prices that are prohibitive for many countries thus restraining the growth of insulin API market in the coming years.

Key Market Driver -

Rising prevalence of Diabetes

Key Market Restraint -

High price for insulin pose a barrier for people living with diabetes

Market Segmentation:

Globally, the Insulin API market can be categorized into type, application and region. Based on type, the market can be segmented into regular human Insulin, insulin Analogue and others. Based on application segmentation, the market can be categorized into fast-acting, long-acting and premix.

Geographically, the Insulin API market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key Players Covered:

Some of the major companies that are present in the Insulin API market are Novo Nordisk A/S, Biocon, Julphar, Torrent Pharmaceuticals Ltd., Eli Lilly and Company., Tonghua Dongbao,  Ganlee, other prominent players.

Key Insights:

  • Key Industry Developments – Merger, Acquisitions, and Partnerships

  • Key Product Launches

  • Key Industry Trends

  • Prevalence of Diabetes

  • COVID-19 Impact on Insulin API Market

Regional Analysis:

Based on region segmentation, the Insulin API market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to dominate the market in 2020 and is estimated to retain its dominating position during the forecast period. Factors such as increasing prevalence of diabetes in north America. In 2018, as per American diabetes association, there were 34.2 million Americans have diabetes which is nearly 10.5% of the population. Along with this the surge in the demand for generic insulin is boosting the growth of the market.  In Europe, the market is stirred by factors such as expansion of business and customer base of the major players. For example, in 2020, Novo Nordisk had announced their plan of investment of USD 117million in upgrading and expanding facilities at its production site in Denmark. The market growth in the Asia Pacific is supplemented by increasing disposable incomes and rising geriatric populations in countries such as India, Japan, and China. Additionally, the existence of key insulin manufacturer and robust competition among them is the driving force. The market in Latin America and Middle East countries, and Africa is expected to grow slower than other regions.

To gain extensive insights into the market, Request for Customization




By Type

  • Regular Human Insulin

  • Insulin Analogue

  • Others

By End-user

  • Fast-acting

  • Long-acting

  • Premix

By Geography

  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)

Anti-Snoring Device Market Industry Developments

  • In February 2020, Sanofi, a Sanofi is planning to create a major leading European company committed to the production and marketing of active pharmaceutical ingredients (API), which are the necessary molecules responsible for the positive effects used in the composition of any drug.

  • In February 2021, Biocon Biologics ltd. biosimilars company and a subsidiary of Biocon Ltd has partnered with The International Diabetes Federation (IDF) as the first biosimilar insulins company for promoting and supporting IDF’s Core Mission initiative and activities

  • Ongoing
  • 2022
  • 2019-2021


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.